Saturday, April 28, 2007

FDA rejects Merck's Vioxx

FDA rejects Merck's Vioxx successor (Reuters)

A pharmacist holds bottles of the prescription arthritis and pain medication VIOXX at a New York City Pharmacy in this September 30, 2004 file photo. Merck said on Friday that U.S. regulators have rejected its arthritis drug Arcoxia, the drugmaker's follow-up to Vioxx, informing the company it cannot be approved without new supportive data. (Mike Segar/Files/Reuters)Reuters - Merck & Co. said on Friday that U.S. regulators have rejected its arthritis drug Arcoxia, the drugmaker's follow-up to Vioxx, informing the company it cannot be approved without new supportive data.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)